Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per sponsor: Amgen
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Study to Evaluate the Safety and action of Etelcalcetide (AMG 416) in Paediatric Subjects Aged 2 to less than 18 Years with Secondary Hyperparathyroidism (sHPT) Receiving Maintenance Haemodialysis
To evaluate the safety and tolerability of etelcalcetide after single dose administration to paediatric subjects aged 2 to less than 18 years with secondary hyperparathyroidism (sHPT) receiving mainte...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Amgen, Inc
Update Il y a 5 ans
A Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
The primary objective of this study is to evaluate if the effect of administering denosumab (60 mg subcutaneously [SC] every 6 months [Q6M]) is not inferior to that of zoledronic acid (5 mg intraveno...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Pembrolizumab (MK 3475) With Talimogene Laherparepvec or placebo in Unresectable Melanoma
Phase 1b: To evaluate the safety, as assessed by incidence of dose limiting toxicity (DLT), of talimogene laherparepvec in combination with pembrolizumab in subjects with previously untreated, unresec...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
A study comparing the use of etanercept and methotrexate, used either alone or in combination for the treatment of Psoriatic Arthritis
To evaluate the efficacy of etanercept plus methotrexate therapy and etanercept monotherapy compared to methotrexate monotherapy, in subjects with psoriatic arthritis as measured by the proportion of...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Study to assess the tolerability and efficacy of AMG 145 in patients with heterozygous familial hypercholesterolemia
To evaluate the effect of 12 weeks of subcutaneous (SC) AMG 145, compared with placebo SC, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in subjects with heterozygous...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 5 ans
Etude JASMINE : étude de phase 3 randomisée en double aveugle visant à évaluer l’efficacité, la sécurité et l’immunogénicité de l’APB798 en comparaison au rituximab chez des patients ayant un lymphome non hodgkinien (LNH) à cellules B CD20 positif. [essai clos aux inclusions]
Le lymphome non hodgkinien est un cancer qui se développe à partir de cellules du système lymphatiques, les lymphocytes B ou T (globules blancs impliqués dans les réactions de défense de l’organisme)....
Country
France
organs
Lymphomes non hodgkinien
Specialty
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Study to assess the tolerability and efficacy of AMG-145 monotherapy in patients with hypercholesterolemia
To evaluate the effect of 12 weeks of subcutaneous AMG 145 every-2-weeks (Q2W) or every-4-weeks (Q4W), compared with placebo, on percent change from baseline in low-density lipoprotein cholesterol (LD...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 5 ans
20090482 : Essai de phase 3 randomisé, en double-aveugle, comparant l’efficacité du dénosumab à l’acide zolédronique dans le traitement des métastases osseuses, chez des patients ayant un myélome multiple. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est de comparer l’efficacité du dénosumab à celle de l’acide zolédronique dans le traitement des métastases osseuses, chez des patients ayant un myélome multiple. Les patients...
Country
France
organs
Myélomes
,
Métastases osseuses
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 6 ans
Étude 20130232 : étude de phase 1-3, randomisée, évaluant la tolérance et l’efficacité de l’association du Talimogene Laherparepvec et du pembrolizumab, chez des patients ayant un cancer de la tête et du cou récidivant ou métastatique. [Informations issues du site clinicaltrials.gov et traduites par l'INCa]
20130232 : Étude de phase 1b/3, multicentrique, randomisée, en ouvert, évaluant l’association du TVEC et du Pembrolizumab chez des patients présentant un carcinome épidermoïde de la tête et du cou réc...
Country
France
organs
Tête et cou
Specialty
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
A Study of the Effects of AMG 334 to Prevent Migraine Headaches
To evaluate the effect of AMG 334 compared to placebo on the change from baseline in mean monthly migraine days, in subjects with episodic migraine
Country
None
organs
None
Specialty
None
unknown
More information
1
2
3
4
5
6
7
8
9
10
Next